Patents by Inventor Jinan Wang

Jinan Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PYRAZOLE-SUBSTITUTED CYCLOPENTANOL ESTER DERIVATIVE AND USE THEREOF
    Publication number: 20250084067
    Abstract: The present application relates to a pyrazole-substituted cyclopentanol ester derivative and use thereof, and in particular to a compound represented by formula (I), an isomer thereof, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: April 27, 2023
    Publication date: March 13, 2025
    Applicant: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
    Inventors: Yinsheng ZHANG, Yong GAO, Bin CAO, Jinan WANG, Damin ZHAO
  • COMPOUND USED AS BCR-ABL INHIBITOR
    Publication number: 20240262807
    Abstract: Provided are a compound used as a BCR-ABL inhibitor, namely a compound of formula (I), or a pharmaceutically acceptable salt thereof, a preparation method therefor, and a pharmaceutical composition comprising the compound. Moreover, the present invention relates to a use of the compound in the preparation of a drug for treating BCR-ABL related diseases.
    Type: Application
    Filed: May 27, 2022
    Publication date: August 8, 2024
    Inventors: Yinsheng ZHANG, Xin LIU, Hui QIN, Jiawei YE, Jinan WANG, Songsong WU
  • SOS1 INHIBITOR CONTAINING PHOSPHORUS
    Publication number: 20240254151
    Abstract: The present application relates to the field of pharmaceutical chemistry, relates to an SOS1 inhibitor containing phosphorus, i.e., a compound of formula (I) and a preparation method therefor, and a pharmaceutical composition containing the compound, and relates to use thereof in the preparation of a drug for treating a disease and/or disorder related to SOS1 or regulated by SOS1.
    Type: Application
    Filed: May 10, 2021
    Publication date: August 1, 2024
    Inventors: Yinsheng Zhang, Baomin Liu, Zhengbang Chen, Jinfa Hu, Yuchen Chen, Kewen Sun, Jinan Wang, Lijuan Zhu
  • METHYL- AND TRIFLUOROMETHYL-CONTAINING DISUBSTITUTED SULFONAMIDE SELECTIVE BCL-2 INHIBITOR
    Publication number: 20220220110
    Abstract: Disclosed is a methyl- and trifluoromethyl-containing disubstituted sulfonamide selective BCL-2 inhibitor; specifically disclosed are a compound of formula I, a stereoisomer or pharmaceutically acceptable salt of same, a preparation method therefor, and a pharmaceutical composition comprising the compound. Also disclosed are uses of the compound and of the pharmaceutical composition comprising the compound in treating anti-apoptotic protein BCL-2-related diseases such as cancer.
    Type: Application
    Filed: May 22, 2020
    Publication date: July 14, 2022
    Applicant: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
    Inventors: Fei LIU, Yanlong LIU, Hongjiang XU, Xiquan ZHANG, Shanchun WANG, Jianqing ZHANG, Weiwei FENG, Bin WANG, Jinan WANG, Yubing WANG, Xujing TANG, Quandeng NIE
  • TRIFLUOROMETHYL-SUBSTITUTED SULFONAMIDE AS BCL-2-SELECTIVE INHIBITOR
    Publication number: 20220002290
    Abstract: Disclosed is a trifluoromethyl-substituted sulfonamide BCL-2-selective inhibitor, in particular disclosed are a compound of formula I, a stereoisomer or a pharmaceutically acceptable salt thereof, a preparation method therefor, and a pharmaceutical composition thereof. Also disclosed are the uses of said compound and of a pharmaceutical composition comprising same for treating anti-apoptotic BCL-2-related diseases, such as cancer.
    Type: Application
    Filed: October 29, 2019
    Publication date: January 6, 2022
    Inventors: Fei Liu, Weiwei Feng, Bin Wang, Hongjiang Xu, Jinan Wang, Xiquan Zhang, Shanchun Wang, Yanlong Liu, Jianqing Zhang, Yiyan Yao, Xujing Tang, Wei Shi, Hongying Zhang, Yang Li, Song Tang, Yizhong Zhu, Limin Liu, Hongmei Gu, Ling Yang